Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor Conferences

Business Wire•30/10/2026•16:05 ET

➤Gilead executives scheduled to present at five healthcare investor conferences in November and December 2026.
➤Webcasts and replays will be available through Gilead’s investor relations website.
➤Gilead operates in more than 35 countries and develops medicines for HIV, hepatitis, COVID-19, and cancer.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

Get started

Create a free account to read the full story.

Already have an account? Log in